These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5290603)

  • 21. PATHOGENESIS AND IMMUNE RESPONSES OF FRANCISELLA TULARENSIS STRAINS IN WILD-CAUGHT COTTONTAIL RABBITS (SYLVILAGUS SPP.).
    Brown VR; Adney DR; Bielefeldt-Ohmann H; Gordy PW; Felix TA; Olea-Popelka FJ; Bowen RA
    J Wildl Dis; 2015 Jul; 51(3):564-75. PubMed ID: 25984770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral immune response of cottontail rabbits naturally infected with Francisella tularensis in southern Illinois.
    Shoemaker D; Woolf A; Kirkpatrick R; Cooper M
    J Wildl Dis; 1997 Oct; 33(4):733-7. PubMed ID: 9391956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of an immunoenzyme method on a solid-phase carrier for determining the tularemia antigen].
    Umnova NS; Shakhanina KL; Pavlova IP; Meshcheriakova IS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):88-92. PubMed ID: 6741370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using two-dimensional gel electrophoresis to study immune response against intracellular bacterial infection.
    Kovarova H; Stulik J; Macela A; Lefkovits I; Skrabkova Z
    Electrophoresis; 1992; 13(9-10):741-2. PubMed ID: 1459105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.
    Tärnvik A; Eriksson M; Sandström G; Sjöstedt A
    Immunology; 1992 Jul; 76(3):349-54. PubMed ID: 1526645
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of human serum and nasal hemagglutinating antibody to Francisella tularensis.
    Bellanti JA; Buescher EL; Brandt WE; Dangerfield HG; Crozier D
    J Immunol; 1967 Jan; 98(1):171-8. PubMed ID: 4163639
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of intradermally administered tularin Sevac on the titre of slow agglutination reaction with the Francisella tularensis antigen (author's transl)].
    Cerný Z
    Cesk Epidemiol Mikrobiol Imunol; 1975 Nov; 24(6):337-43. PubMed ID: 130981
    [No Abstract]   [Full Text] [Related]  

  • 29. [Development of a serological micromethod for the detection of antibodies against Francisella tularensis].
    Nunes MP; Ricciardi ID
    An Microbiol (Rio J); 1980; 25():61-7. PubMed ID: 6982628
    [No Abstract]   [Full Text] [Related]  

  • 30. Virulence of representative Japanese Francisella tularensis and immunologic consequences of infection in mice.
    Hotta A; Fujita O; Uda A; Yamamoto Y; Sharma N; Tanabayashi K; Yamada A; Morikawa S
    Microbiol Immunol; 2016 Mar; 60(3):168-76. PubMed ID: 26853540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an immunochromatographic test for rapid and reliable serodiagnosis of human tularemia and detection of Francisella tularensis-specific antibodies in sera from different mammalian species.
    Splettstoesser W; Guglielmo-Viret V; Seibold E; Thullier P
    J Clin Microbiol; 2010 May; 48(5):1629-34. PubMed ID: 20220165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The laboratory diagnosis of tularemia.
    Brown M
    Va Med Mon (1918); 1970 Jun; 97(6):388-90. PubMed ID: 5528117
    [No Abstract]   [Full Text] [Related]  

  • 33. Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    O'Malley KJ; Bowling JD; Stinson E; Cole KS; Mann BJ; Namjoshi P; Hazlett KRO; Barry EM; Reed DS
    PLoS One; 2018; 13(10):e0205928. PubMed ID: 30346998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the enzyme-linked immunosorbent assay for the serodiagnosis of tularemia].
    Rastawicki W; Jagielski M; Gierczyński R
    Med Dosw Mikrobiol; 2005; 57(4):425-9. PubMed ID: 16773836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Streptococcus bovis and Streptococcus salivarius in clinical laboratories.
    Ruoff KL; Ferraro MJ; Holden J; Kunz LJ
    J Clin Microbiol; 1984 Aug; 20(2):223-6. PubMed ID: 6490816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tularemia vaccine strain is a potential vector].
    Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
    Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The components of Francisella tularensis protective antigene complex].
    Kuznetsova EM; Volokh OA; Shepelev IA; Nikiforov AK
    Mol Gen Mikrobiol Virusol; 2012; (3):22-5. PubMed ID: 22984769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.
    Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A
    Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Time course of the production of immunoglobulins in patients with tularemia].
    Ohara S; Sato T; Homma M
    Nihon Saikingaku Zasshi; 1984 Mar; 39(2):103-6. PubMed ID: 6748218
    [No Abstract]   [Full Text] [Related]  

  • 40. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.